Biological Activities of Chinese Propolis and Brazilian Propolis on Streptozotocin‐Induced Type 1 Diabetes Mellitus in Rats
Authors:
Open Access
- 1 January 2011
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2011 (1) , 1-8
Abstract
Propolis is a bee‐collected natural product and has been proven to have various bioactivities. This study tested the effects of Chinese propolis and Brazilian propolis on streptozotocin‐induced type 1 diabetes mellitus in Sprague‐Dawley rats. The results showed that Chinese propolis and Brazilian propolis significantly inhibited body weight loss and blood glucose increase in diabetic rats. In addition, Chinese propolis‐treated rats showed an 8.4% reduction of glycated hemoglobin levels compared with untreated diabetic rats. Measurement of blood lipid metabolism showed dyslipidemia in diabetic rats and Chinese propolis helped to reduce total cholesterol level by 16.6%. Moreover, oxidative stress in blood, liver and kidney was improved to various degrees by both Chinese propolis and Brazilian propolis. An apparent reduction in levels of alanine transaminase, aspartate transaminase, blood urea nitrogen and urine microalbuminuria‐excretion rate demonstrated the beneficial effects of propolis in hepatorenal function. All these results suggested that Chinese propolis and Brazilian propolis can alleviate symptoms of diabetes mellitus in rats and these effects may partially be due to their antioxidant ability.Keywords
This publication has 51 references indexed in Scilit:
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Economic Costs of Diabetes in the U.S. in 2007Diabetes Care, 2008
- Seasonal Variation, Chemical Composition and Antioxidant Activity of Brazilian Propolis SamplesEvidence-Based Complementary and Alternative Medicine, 2007
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Management of Dyslipidemias in Patients with Diabetes and Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2006
- Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trialsAmerican Heart Journal, 2006
- Animal models of diabetes mellitusDiabetic Medicine, 2005
- Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin‐induced nephrotoxicity in ratsJournal of Applied Toxicology, 2004
- Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic ratsBiochemical Society Transactions, 2003
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998